Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Transdermal Skin Patches Market Valued at Present and by 2029?

The market size for transdermal skin patches has been witnessing consistent growth in the past few years. The market is predicted to flourish from $7.46 billion in 2024 to $7.65 billion in 2025 with a compound annual growth rate (CAGR) of 2.5%. Factors that contributed to the growth in the historical period include a rising occurrence of cardiovascular diseases, the robust economic growth in burgeoning markets, amplified spending in pharmaceutical research and development, and increased expenses in healthcare.

The market size of transdermal skin patches is anticipated to steadily increase in the upcoming years, growing to “$9.18 billion in 2029, with a compound annual growth rate (CAGR) of 4.7+%. This growth in the forecast period can be credited to factors such as a rise in smoking cessation, swift growth in the elderly population, escalating health care costs, and an upsurge in cardiovascular diseases. Key trends expected during the forecast period encompass technological progress in transdermal skin patches, advancements in diabetes skin patches, significant research and development undertakings, product innovation, collaborations and alliances, wearable skin patches, improvements in micro-needle patches for vaccinations, and new iontophoresis patches.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2829&type=smp

#What Drivers Are Influencing Growth In The Transdermal Skin Patches Market?

The predicted rise in the incidence of cardiovascular disease is expected to drive the transdermal skin patches market’s development. These diseases affecting the heart and blood vessels are generally accompanied by accumulation of fatty deposits within the arteries (atherosclerosis) and increased susceptibility to blood clots. Transdermal skin patches play a critical role in preventing angina episodes among individuals with coronary artery disease, which involves the narrowing of blood vessels that provide blood to the heart. They are also utilized to enhance bioavailability in heart failure management. For example, a report released by the American College of Cardiology in August 2022 forecasts a growing trend in all four cardiovascular risk factors in the United States from 2025 to 2060. Diabetes is predicted to ascend by 39.3% to 55 million people, the highest rate, followed by dyslipidemia (an increase of 27.6% to 126 million), hypertension (a raise of 25.1% to 162 million), and obesity (an surge of 18.3% to 126 million). The study also indicated that stroke (a rise of 33.8% to 15 million) and heart failure (an increase of 33.4% to 13 million) exhibited the most significant expected augmentation in cardiovascular disease rates, followed by ischemic heart disease (an increase of 30.7% to 29 million) and heart attack (a surge of 16.9% to 16 million). Hence, this growing trend in cardiovascular disease prevalence is boosting the transdermal skin patches market.

The transdermal skin patches market covered in this report is segmented –

1) By Product: Matrix, Drug In Adhesive, Reservoir, Vapor

2) By Type: Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, Other Types

3) By Distribution Channel: Pain Relief, Nicotine Cessation,Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, Other Applications

Subsegments:

1) By Matrix: Drug-in-matrix Patches, Polymer Matrix Patches

2) By Drug In Adhesive: Adhesive Matrix Patches With The Drug Incorporated In The Adhesive Layer

3) By Reservoir: Drug Reservoir Patches With A Separate Compartment For The Drug, Multi-layer Reservoir Patches

4) By Vapor: Vapor Patches That Release Active Ingredients In Vapor Form, Transdermal Patches Utilizing Vaporization Technology

What Notable Trends Are Shaping The Direction Of The Transdermal Skin Patches Market?

Leading players in the transdermal skin patches sector are focusing more on the development and approval of innovative items to achieve market dominance. Innovative items are those that provide new or enhanced solutions, such as drugs, medical devices, or other products, to address existing issues or demands. One such example is Noven Pharmaceuticals Inc., an American pharmaceutical company, which recently, in March 2022, got the approval from the U.S. Food and Drug Administration (FDA), an American federal agency, for its XELSTRY (dextroamphetamine) transdermal system. This system is the first of its kind; an approved amphetamine patch used to treat ADHD (Attention-Deficit or Hyperactivity Disorder). To achieve desired effects, XELSTRYM should be applied two hours in advance and removed nine hours later. The ultimate dosage should be customized based on patient response and tolerance.

Which Companies Play A Key Role In The Development Of The Transdermal Skin Patches Market?

Major companies operating in the transdermal skin patches market include Novartis, Hisamitsu Pharmaceutical Co., Inc, Henan Lingrui Pharmaceutical, Teva Pharmaceuticals, Luye Pharma Group Ltd, Purdue Pharma L.P., Nitto Denko Corporation, AdhexPharma, Noven Pharmaceuticals, Teikoku Pharma, Mylan Pharmaceuticals Inc, 3M Company, Acrux Ltd, Access Pharmaceuticals Inc, Rusan Pharma, Glenmark Pharmaceuticals, Cipla Ltd, Mundipharma, Dr Reddy’s Laboratories, Chattem, Clarity Medical, Welcare Industries S.P. A, F.L. Medical S.r.l, Europlaz Technologies Ltd, Zentiva, Medical-Łomża Sp. z o.o., Johnson & Johnson, Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Endo Pharmaceuticals Inc.

https://www.thebusinessresearchcompany.com/report/transdermal-skin-patche-global-market-report

What Are The Key Regional Developments Shaping The Transdermal Skin Patches Market?

North America was the largest region in the global transdermal skin patches market in 2024. Middle East is expected to be the fastest growing region in the transdermal skin patches market report during the forecast period. The regions covered in the transdermal skin patches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2829&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model